Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas E. Herman currently holds 25,227.81 shares of Calamos Aksia Alternative Credit & Income Fund (CAPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas E. Herman has been a net buyer of CAPIX stock. They have purchased $1.8M and sold $200.0K worth of shares.
Thomas E. Herman's most recent insider trade was on Feb 4, 2026, when they purchased 5,324.3 shares at $10.33 per share.
Thomas E. Herman serves as Executive at Calamos Aksia Alternative Credit & Income Fund (CAPIX). They have executed 14 insider transactions totaling $2.0M over their tenure at the company.
Thomas E. Herman holds the position of Executive at Calamos Aksia Alternative Credit & Income Fund, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Thomas E. Herman has shown a buying trading pattern, with $1.8M in total purchases and $200.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas E. Herman was on Jul 7, 2025, when they purchased $450.4K worth of N.A. shares. This transaction involved 44,995.05 shares at $10.01 per share.
Thomas E. Herman currently owns 25,227.81 shares of Calamos Aksia Alternative Credit & Income Fund (CAPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas E. Herman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas E. Herman has 14 Form 4 filings on record as an insider at Calamos Aksia Alternative Credit & Income Fund.
Set alerts for Thomas E. Herman and 40,000+ other insiders.